nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—Hepatic insufficiency—Azathioprine—multiple sclerosis	0.0749	0.0977	CcSEcCtD
Diclofenamide—Metabolic acidosis—Cladribine—multiple sclerosis	0.0361	0.047	CcSEcCtD
Diclofenamide—Hepatic insufficiency—Methotrexate—multiple sclerosis	0.0302	0.0394	CcSEcCtD
Diclofenamide—CA1—nerve—multiple sclerosis	0.0212	0.0908	CbGeAlD
Diclofenamide—Metabolic acidosis—Methylprednisolone—multiple sclerosis	0.0178	0.0233	CcSEcCtD
Diclofenamide—Electrolyte imbalance—Methylprednisolone—multiple sclerosis	0.0169	0.022	CcSEcCtD
Diclofenamide—CA4—nerve—multiple sclerosis	0.0166	0.071	CbGeAlD
Diclofenamide—Hyperuricaemia—Cladribine—multiple sclerosis	0.0154	0.02	CcSEcCtD
Diclofenamide—Electrolyte imbalance—Betamethasone—multiple sclerosis	0.0154	0.02	CcSEcCtD
Diclofenamide—Electrolyte imbalance—Dexamethasone—multiple sclerosis	0.0154	0.02	CcSEcCtD
Diclofenamide—Blood uric acid increased—Cladribine—multiple sclerosis	0.0145	0.0189	CcSEcCtD
Diclofenamide—Weight decreased—Fingolimod—multiple sclerosis	0.0143	0.0186	CcSEcCtD
Diclofenamide—Disorientation—Cladribine—multiple sclerosis	0.0116	0.0151	CcSEcCtD
Diclofenamide—Hepatic failure—Cladribine—multiple sclerosis	0.0115	0.015	CcSEcCtD
Diclofenamide—CA7—midbrain—multiple sclerosis	0.0113	0.0483	CbGeAlD
Diclofenamide—CA14—medulla oblongata—multiple sclerosis	0.0103	0.044	CbGeAlD
Diclofenamide—Hyperuricaemia—Mitoxantrone—multiple sclerosis	0.0101	0.0132	CcSEcCtD
Diclofenamide—Leukopenia—Fingolimod—multiple sclerosis	0.00984	0.0128	CcSEcCtD
Diclofenamide—Ataxia—Cladribine—multiple sclerosis	0.00973	0.0127	CcSEcCtD
Diclofenamide—Blood uric acid increased—Mitoxantrone—multiple sclerosis	0.00954	0.0124	CcSEcCtD
Diclofenamide—CA14—midbrain—multiple sclerosis	0.00938	0.0402	CbGeAlD
Diclofenamide—Hepatic failure—Azathioprine—multiple sclerosis	0.00936	0.0122	CcSEcCtD
Diclofenamide—CA14—spinal cord—multiple sclerosis	0.00915	0.0392	CbGeAlD
Diclofenamide—CA7—cerebellum—multiple sclerosis	0.00871	0.0374	CbGeAlD
Diclofenamide—Paraesthesia—Fingolimod—multiple sclerosis	0.00806	0.0105	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00774	0.0101	CcSEcCtD
Diclofenamide—Fatigue—Fingolimod—multiple sclerosis	0.00773	0.0101	CcSEcCtD
Diclofenamide—CA9—cerebellum—multiple sclerosis	0.00765	0.0328	CbGeAlD
Diclofenamide—Eruption—Methotrexate—multiple sclerosis	0.00759	0.0099	CcSEcCtD
Diclofenamide—CA14—cerebellum—multiple sclerosis	0.00726	0.0311	CbGeAlD
Diclofenamide—CA4—brainstem—multiple sclerosis	0.00711	0.0305	CbGeAlD
Diclofenamide—CA7—brain—multiple sclerosis	0.00708	0.0303	CbGeAlD
Diclofenamide—Asthenia—Fingolimod—multiple sclerosis	0.00644	0.00839	CcSEcCtD
Diclofenamide—Pruritus—Fingolimod—multiple sclerosis	0.00635	0.00828	CcSEcCtD
Diclofenamide—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.00619	0.00807	CcSEcCtD
Diclofenamide—Agranulocytosis—Azathioprine—multiple sclerosis	0.00605	0.00789	CcSEcCtD
Diclofenamide—CA12—nervous system—multiple sclerosis	0.00602	0.0258	CbGeAlD
Diclofenamide—Dizziness—Fingolimod—multiple sclerosis	0.00593	0.00774	CcSEcCtD
Diclofenamide—CA14—brain—multiple sclerosis	0.0059	0.0253	CbGeAlD
Diclofenamide—CA2—brainstem—multiple sclerosis	0.00589	0.0253	CbGeAlD
Diclofenamide—CA12—central nervous system—multiple sclerosis	0.00579	0.0248	CbGeAlD
Diclofenamide—CA2—retina—multiple sclerosis	0.00569	0.0244	CbGeAlD
Diclofenamide—CA1—spinal cord—multiple sclerosis	0.00566	0.0242	CbGeAlD
Diclofenamide—Headache—Fingolimod—multiple sclerosis	0.00562	0.00733	CcSEcCtD
Diclofenamide—CA5B—nervous system—multiple sclerosis	0.0054	0.0231	CbGeAlD
Diclofenamide—Weight decreased—Mitoxantrone—multiple sclerosis	0.00532	0.00694	CcSEcCtD
Diclofenamide—Drowsiness—Mitoxantrone—multiple sclerosis	0.00524	0.00684	CcSEcCtD
Diclofenamide—CA5B—central nervous system—multiple sclerosis	0.0052	0.0223	CbGeAlD
Diclofenamide—Confusional state—Cladribine—multiple sclerosis	0.00513	0.00669	CcSEcCtD
Diclofenamide—Hyperuricaemia—Methotrexate—multiple sclerosis	0.00503	0.00656	CcSEcCtD
Diclofenamide—Thrombocytopenia—Cladribine—multiple sclerosis	0.00498	0.00649	CcSEcCtD
Diclofenamide—CA4—medulla oblongata—multiple sclerosis	0.00496	0.0212	CbGeAlD
Diclofenamide—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00489	0.00638	CcSEcCtD
Diclofenamide—Anorexia—Cladribine—multiple sclerosis	0.00485	0.00632	CcSEcCtD
Diclofenamide—CA1—nervous system—multiple sclerosis	0.00477	0.0204	CbGeAlD
Diclofenamide—Blood uric acid increased—Methotrexate—multiple sclerosis	0.00475	0.0062	CcSEcCtD
Diclofenamide—CA12—brain—multiple sclerosis	0.0046	0.0197	CbGeAlD
Diclofenamide—CA1—central nervous system—multiple sclerosis	0.00459	0.0197	CbGeAlD
Diclofenamide—Paraesthesia—Cladribine—multiple sclerosis	0.00457	0.00596	CcSEcCtD
Diclofenamide—Leukopenia—Azathioprine—multiple sclerosis	0.00453	0.00591	CcSEcCtD
Diclofenamide—CA4—midbrain—multiple sclerosis	0.00453	0.0194	CbGeAlD
Diclofenamide—Somnolence—Cladribine—multiple sclerosis	0.00452	0.0059	CcSEcCtD
Diclofenamide—Decreased appetite—Cladribine—multiple sclerosis	0.00442	0.00577	CcSEcCtD
Diclofenamide—CA4—spinal cord—multiple sclerosis	0.00442	0.0189	CbGeAlD
Diclofenamide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00439	0.00573	CcSEcCtD
Diclofenamide—Fatigue—Cladribine—multiple sclerosis	0.00438	0.00572	CcSEcCtD
Diclofenamide—Constipation—Cladribine—multiple sclerosis	0.00435	0.00567	CcSEcCtD
Diclofenamide—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00424	0.00553	CcSEcCtD
Diclofenamide—Hypokalaemia—Betamethasone—multiple sclerosis	0.00424	0.00553	CcSEcCtD
Diclofenamide—Feeling abnormal—Cladribine—multiple sclerosis	0.00419	0.00547	CcSEcCtD
Diclofenamide—CA5B—brain—multiple sclerosis	0.00412	0.0177	CbGeAlD
Diclofenamide—CA2—medulla oblongata—multiple sclerosis	0.00411	0.0176	CbGeAlD
Diclofenamide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00405	0.00528	CcSEcCtD
Diclofenamide—Body temperature increased—Cladribine—multiple sclerosis	0.00402	0.00524	CcSEcCtD
Diclofenamide—Hepatic failure—Methotrexate—multiple sclerosis	0.00377	0.00492	CcSEcCtD
Diclofenamide—CA2—midbrain—multiple sclerosis	0.00376	0.0161	CbGeAlD
Diclofenamide—CA4—nervous system—multiple sclerosis	0.00372	0.016	CbGeAlD
Diclofenamide—Hypokalaemia—Prednisone—multiple sclerosis	0.00369	0.00481	CcSEcCtD
Diclofenamide—Leukopenia—Mitoxantrone—multiple sclerosis	0.00367	0.00478	CcSEcCtD
Diclofenamide—CA2—spinal cord—multiple sclerosis	0.00367	0.0157	CbGeAlD
Diclofenamide—Asthenia—Cladribine—multiple sclerosis	0.00365	0.00476	CcSEcCtD
Diclofenamide—CA1—brain—multiple sclerosis	0.00364	0.0156	CbGeAlD
Diclofenamide—Weight decreased—Betamethasone—multiple sclerosis	0.00364	0.00475	CcSEcCtD
Diclofenamide—Weight decreased—Dexamethasone—multiple sclerosis	0.00364	0.00475	CcSEcCtD
Diclofenamide—Pruritus—Cladribine—multiple sclerosis	0.0036	0.00469	CcSEcCtD
Diclofenamide—CA4—central nervous system—multiple sclerosis	0.00359	0.0154	CbGeAlD
Diclofenamide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00357	0.00466	CcSEcCtD
Diclofenamide—CA4—cerebellum—multiple sclerosis	0.00351	0.015	CbGeAlD
Diclofenamide—Feeling abnormal—Azathioprine—multiple sclerosis	0.00341	0.00444	CcSEcCtD
Diclofenamide—Confusional state—Mitoxantrone—multiple sclerosis	0.00337	0.0044	CcSEcCtD
Diclofenamide—Dizziness—Cladribine—multiple sclerosis	0.00336	0.00439	CcSEcCtD
Diclofenamide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00327	0.00427	CcSEcCtD
Diclofenamide—Body temperature increased—Azathioprine—multiple sclerosis	0.00327	0.00426	CcSEcCtD
Diclofenamide—Vomiting—Cladribine—multiple sclerosis	0.00323	0.00422	CcSEcCtD
Diclofenamide—Rash—Cladribine—multiple sclerosis	0.00321	0.00418	CcSEcCtD
Diclofenamide—Anorexia—Mitoxantrone—multiple sclerosis	0.00319	0.00416	CcSEcCtD
Diclofenamide—Ataxia—Methotrexate—multiple sclerosis	0.00319	0.00416	CcSEcCtD
Diclofenamide—Headache—Cladribine—multiple sclerosis	0.00319	0.00416	CcSEcCtD
Diclofenamide—Weight decreased—Prednisone—multiple sclerosis	0.00317	0.00413	CcSEcCtD
Diclofenamide—CA2—nervous system—multiple sclerosis	0.00309	0.0132	CbGeAlD
Diclofenamide—Nausea—Cladribine—multiple sclerosis	0.00302	0.00394	CcSEcCtD
Diclofenamide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.003	0.00391	CcSEcCtD
Diclofenamide—CA2—central nervous system—multiple sclerosis	0.00297	0.0127	CbGeAlD
Diclofenamide—Somnolence—Mitoxantrone—multiple sclerosis	0.00297	0.00388	CcSEcCtD
Diclofenamide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00294	0.00384	CcSEcCtD
Diclofenamide—CA2—cerebellum—multiple sclerosis	0.00291	0.0125	CbGeAlD
Diclofenamide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00291	0.00379	CcSEcCtD
Diclofenamide—Fatigue—Mitoxantrone—multiple sclerosis	0.00288	0.00376	CcSEcCtD
Diclofenamide—Constipation—Mitoxantrone—multiple sclerosis	0.00286	0.00373	CcSEcCtD
Diclofenamide—CA4—brain—multiple sclerosis	0.00285	0.0122	CbGeAlD
Diclofenamide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00275	0.00359	CcSEcCtD
Diclofenamide—Dizziness—Azathioprine—multiple sclerosis	0.00273	0.00357	CcSEcCtD
Diclofenamide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00264	0.00345	CcSEcCtD
Diclofenamide—Vomiting—Azathioprine—multiple sclerosis	0.00263	0.00343	CcSEcCtD
Diclofenamide—Drowsiness—Methotrexate—multiple sclerosis	0.00261	0.00341	CcSEcCtD
Diclofenamide—Rash—Azathioprine—multiple sclerosis	0.00261	0.0034	CcSEcCtD
Diclofenamide—Headache—Azathioprine—multiple sclerosis	0.00259	0.00338	CcSEcCtD
Diclofenamide—Confusional state—Methylprednisolone—multiple sclerosis	0.00254	0.00331	CcSEcCtD
Diclofenamide—Paraesthesia—Prednisolone—multiple sclerosis	0.00246	0.00321	CcSEcCtD
Diclofenamide—Nausea—Azathioprine—multiple sclerosis	0.00246	0.0032	CcSEcCtD
Diclofenamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.00244	0.00318	CcSEcCtD
Diclofenamide—Asthenia—Mitoxantrone—multiple sclerosis	0.0024	0.00313	CcSEcCtD
Diclofenamide—CA2—brain—multiple sclerosis	0.00236	0.0101	CbGeAlD
Diclofenamide—Paraesthesia—Triamcinolone—multiple sclerosis	0.00226	0.00295	CcSEcCtD
Diclofenamide—Feeling abnormal—Prednisolone—multiple sclerosis	0.00226	0.00295	CcSEcCtD
Diclofenamide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00226	0.00295	CcSEcCtD
Diclofenamide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00224	0.00292	CcSEcCtD
Diclofenamide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00224	0.00292	CcSEcCtD
Diclofenamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.00222	0.0029	CcSEcCtD
Diclofenamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00221	0.00289	CcSEcCtD
Diclofenamide—Tinnitus—Methotrexate—multiple sclerosis	0.00219	0.00285	CcSEcCtD
Diclofenamide—Anorexia—Betamethasone—multiple sclerosis	0.00218	0.00284	CcSEcCtD
Diclofenamide—Anorexia—Dexamethasone—multiple sclerosis	0.00218	0.00284	CcSEcCtD
Diclofenamide—Fatigue—Triamcinolone—multiple sclerosis	0.00217	0.00284	CcSEcCtD
Diclofenamide—Fatigue—Methylprednisolone—multiple sclerosis	0.00217	0.00283	CcSEcCtD
Diclofenamide—Vomiting—Mitoxantrone—multiple sclerosis	0.00213	0.00277	CcSEcCtD
Diclofenamide—Rash—Mitoxantrone—multiple sclerosis	0.00211	0.00275	CcSEcCtD
Diclofenamide—Headache—Mitoxantrone—multiple sclerosis	0.00209	0.00273	CcSEcCtD
Diclofenamide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00208	0.00271	CcSEcCtD
Diclofenamide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00207	0.0027	CcSEcCtD
Diclofenamide—Paraesthesia—Betamethasone—multiple sclerosis	0.00205	0.00268	CcSEcCtD
Diclofenamide—Paraesthesia—Dexamethasone—multiple sclerosis	0.00205	0.00268	CcSEcCtD
Diclofenamide—Dyspepsia—Betamethasone—multiple sclerosis	0.00201	0.00263	CcSEcCtD
Diclofenamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.00201	0.00263	CcSEcCtD
Diclofenamide—Body temperature increased—Triamcinolone—multiple sclerosis	0.00199	0.0026	CcSEcCtD
Diclofenamide—Decreased appetite—Betamethasone—multiple sclerosis	0.00199	0.00259	CcSEcCtD
Diclofenamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.00199	0.00259	CcSEcCtD
Diclofenamide—Nausea—Mitoxantrone—multiple sclerosis	0.00199	0.00259	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00198	0.00258	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00198	0.00258	CcSEcCtD
Diclofenamide—Fatigue—Betamethasone—multiple sclerosis	0.00197	0.00257	CcSEcCtD
Diclofenamide—Fatigue—Dexamethasone—multiple sclerosis	0.00197	0.00257	CcSEcCtD
Diclofenamide—Anorexia—Prednisone—multiple sclerosis	0.0019	0.00248	CcSEcCtD
Diclofenamide—Feeling abnormal—Betamethasone—multiple sclerosis	0.00189	0.00246	CcSEcCtD
Diclofenamide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00189	0.00246	CcSEcCtD
Diclofenamide—Leukopenia—Methotrexate—multiple sclerosis	0.00183	0.00238	CcSEcCtD
Diclofenamide—Dizziness—Prednisolone—multiple sclerosis	0.00181	0.00237	CcSEcCtD
Diclofenamide—Asthenia—Triamcinolone—multiple sclerosis	0.00181	0.00236	CcSEcCtD
Diclofenamide—Body temperature increased—Betamethasone—multiple sclerosis	0.00181	0.00236	CcSEcCtD
Diclofenamide—Body temperature increased—Dexamethasone—multiple sclerosis	0.00181	0.00236	CcSEcCtD
Diclofenamide—Asthenia—Methylprednisolone—multiple sclerosis	0.00181	0.00235	CcSEcCtD
Diclofenamide—Paraesthesia—Prednisone—multiple sclerosis	0.00179	0.00233	CcSEcCtD
Diclofenamide—Pruritus—Triamcinolone—multiple sclerosis	0.00178	0.00233	CcSEcCtD
Diclofenamide—Pruritus—Methylprednisolone—multiple sclerosis	0.00178	0.00232	CcSEcCtD
Diclofenamide—Dyspepsia—Prednisone—multiple sclerosis	0.00175	0.00229	CcSEcCtD
Diclofenamide—Decreased appetite—Prednisone—multiple sclerosis	0.00173	0.00226	CcSEcCtD
Diclofenamide—Rash—Prednisolone—multiple sclerosis	0.00173	0.00226	CcSEcCtD
Diclofenamide—Fatigue—Prednisone—multiple sclerosis	0.00172	0.00224	CcSEcCtD
Diclofenamide—Headache—Prednisolone—multiple sclerosis	0.00172	0.00224	CcSEcCtD
Diclofenamide—Constipation—Prednisone—multiple sclerosis	0.0017	0.00222	CcSEcCtD
Diclofenamide—Confusional state—Methotrexate—multiple sclerosis	0.00168	0.00219	CcSEcCtD
Diclofenamide—Dizziness—Triamcinolone—multiple sclerosis	0.00167	0.00218	CcSEcCtD
Diclofenamide—Dizziness—Methylprednisolone—multiple sclerosis	0.00166	0.00217	CcSEcCtD
Diclofenamide—Feeling abnormal—Prednisone—multiple sclerosis	0.00164	0.00214	CcSEcCtD
Diclofenamide—Asthenia—Betamethasone—multiple sclerosis	0.00164	0.00214	CcSEcCtD
Diclofenamide—Asthenia—Dexamethasone—multiple sclerosis	0.00164	0.00214	CcSEcCtD
Diclofenamide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00163	0.00213	CcSEcCtD
Diclofenamide—Nausea—Prednisolone—multiple sclerosis	0.00163	0.00212	CcSEcCtD
Diclofenamide—Pruritus—Dexamethasone—multiple sclerosis	0.00162	0.00211	CcSEcCtD
Diclofenamide—Pruritus—Betamethasone—multiple sclerosis	0.00162	0.00211	CcSEcCtD
Diclofenamide—Vomiting—Triamcinolone—multiple sclerosis	0.0016	0.00209	CcSEcCtD
Diclofenamide—Vomiting—Methylprednisolone—multiple sclerosis	0.0016	0.00209	CcSEcCtD
Diclofenamide—Rash—Triamcinolone—multiple sclerosis	0.00159	0.00207	CcSEcCtD
Diclofenamide—Anorexia—Methotrexate—multiple sclerosis	0.00159	0.00207	CcSEcCtD
Diclofenamide—Rash—Methylprednisolone—multiple sclerosis	0.00159	0.00207	CcSEcCtD
Diclofenamide—Headache—Triamcinolone—multiple sclerosis	0.00158	0.00206	CcSEcCtD
Diclofenamide—Headache—Methylprednisolone—multiple sclerosis	0.00158	0.00206	CcSEcCtD
Diclofenamide—Body temperature increased—Prednisone—multiple sclerosis	0.00158	0.00205	CcSEcCtD
Diclofenamide—Dizziness—Dexamethasone—multiple sclerosis	0.00151	0.00197	CcSEcCtD
Diclofenamide—Dizziness—Betamethasone—multiple sclerosis	0.00151	0.00197	CcSEcCtD
Diclofenamide—Nausea—Triamcinolone—multiple sclerosis	0.0015	0.00195	CcSEcCtD
Diclofenamide—Paraesthesia—Methotrexate—multiple sclerosis	0.0015	0.00195	CcSEcCtD
Diclofenamide—Nausea—Methylprednisolone—multiple sclerosis	0.00149	0.00195	CcSEcCtD
Diclofenamide—Somnolence—Methotrexate—multiple sclerosis	0.00148	0.00193	CcSEcCtD
Diclofenamide—Dyspepsia—Methotrexate—multiple sclerosis	0.00147	0.00191	CcSEcCtD
Diclofenamide—Vomiting—Dexamethasone—multiple sclerosis	0.00145	0.0019	CcSEcCtD
Diclofenamide—Vomiting—Betamethasone—multiple sclerosis	0.00145	0.0019	CcSEcCtD
Diclofenamide—Decreased appetite—Methotrexate—multiple sclerosis	0.00145	0.00189	CcSEcCtD
Diclofenamide—Rash—Dexamethasone—multiple sclerosis	0.00144	0.00188	CcSEcCtD
Diclofenamide—Rash—Betamethasone—multiple sclerosis	0.00144	0.00188	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00144	0.00188	CcSEcCtD
Diclofenamide—Fatigue—Methotrexate—multiple sclerosis	0.00144	0.00187	CcSEcCtD
Diclofenamide—Headache—Betamethasone—multiple sclerosis	0.00143	0.00187	CcSEcCtD
Diclofenamide—Headache—Dexamethasone—multiple sclerosis	0.00143	0.00187	CcSEcCtD
Diclofenamide—Asthenia—Prednisone—multiple sclerosis	0.00143	0.00186	CcSEcCtD
Diclofenamide—Pruritus—Prednisone—multiple sclerosis	0.00141	0.00184	CcSEcCtD
Diclofenamide—Feeling abnormal—Methotrexate—multiple sclerosis	0.00137	0.00179	CcSEcCtD
Diclofenamide—Nausea—Betamethasone—multiple sclerosis	0.00136	0.00177	CcSEcCtD
Diclofenamide—Nausea—Dexamethasone—multiple sclerosis	0.00136	0.00177	CcSEcCtD
Diclofenamide—Dizziness—Prednisone—multiple sclerosis	0.00132	0.00172	CcSEcCtD
Diclofenamide—Body temperature increased—Methotrexate—multiple sclerosis	0.00132	0.00172	CcSEcCtD
Diclofenamide—Vomiting—Prednisone—multiple sclerosis	0.00127	0.00165	CcSEcCtD
Diclofenamide—Rash—Prednisone—multiple sclerosis	0.00126	0.00164	CcSEcCtD
Diclofenamide—Headache—Prednisone—multiple sclerosis	0.00125	0.00163	CcSEcCtD
Diclofenamide—Asthenia—Methotrexate—multiple sclerosis	0.00119	0.00156	CcSEcCtD
Diclofenamide—Nausea—Prednisone—multiple sclerosis	0.00118	0.00154	CcSEcCtD
Diclofenamide—Pruritus—Methotrexate—multiple sclerosis	0.00118	0.00154	CcSEcCtD
Diclofenamide—Dizziness—Methotrexate—multiple sclerosis	0.0011	0.00144	CcSEcCtD
Diclofenamide—Vomiting—Methotrexate—multiple sclerosis	0.00106	0.00138	CcSEcCtD
Diclofenamide—Rash—Methotrexate—multiple sclerosis	0.00105	0.00137	CcSEcCtD
Diclofenamide—Headache—Methotrexate—multiple sclerosis	0.00104	0.00136	CcSEcCtD
Diclofenamide—Nausea—Methotrexate—multiple sclerosis	0.000989	0.00129	CcSEcCtD
